HERON THERAPEUTICS INC shareholders Q3 2023

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 140 filers reported holding HERON THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.8%.

HERON THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Douglas Lane & Associates, LLC 10,000$10,3000.00%
OSAIC HOLDINGS, INC. 19,158$19,7320.00%
FMR LLC 280,499$288,9140.00%
ROYAL BANK OF CANADA 15,221$16,0000.00%
BARCLAYS PLC 54,710$560.00%
HUNTINGTON NATIONAL BANK 370$3810.00%
AMERICAN INTERNATIONAL GROUP, INC. 51,675$53,2250.00%
Parallel Advisors, LLC 200$2060.00%
BANK OF AMERICA CORP /DE/ 91,784$94,5380.00%
AQR Capital Management 122,767$126,4500.00%
PNC FINANCIAL SERVICES GROUP, INC. 1,708$1,7590.00%
STIFEL FINANCIAL CORP 33,213$34,2170.00%
METROPOLITAN LIFE INSURANCE CO/NY 6,161$6,3460.00%
Russell Investments Group, Ltd. 200$2060.00%
WELLS FARGO & COMPANY/MN 30,509$31,4240.00%
NORTHERN TRUST CORP 1,022,605$1,053,2830.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 1,580$1,6270.00%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 19,603$20,1910.00%
Legal & General Group Plc 11,833$12,2470.00%
GEODE CAPITAL MANAGEMENT, LLC 2,395,161$2,467,3940.00%
External links

This page lists HERON THERAPEUTICS INC's shareholders in Q3 2023. To view HERON THERAPEUTICS INC's shareholder history, click here.